FDA Approval Activities for this Drug…

Synarel (nafarelin acetate) 200 mcg nasal solution, only Searle NDA 19-886/S-013 12/24/98 12/29/98 7/21/99 Synarel Indication:provides for revisions to the CLINICAL PHARMACOLOGY and ADVERSE REACTIONS sections of the labeling (endometriosis)

For the latest approval information and links for this API, please see the main page.